Clinical trial
Drotaverine in Dysmenorrhoea Treatment
NCT00292747 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00292747 |
|---|---|
| Title | Drotaverine in Dysmenorrhoea Treatment |
| Official title | Comparison of the Efficacy and Tolerability of Drotaverine 80 mg, Ibuprofen 400 mg and Their Combination in a Calendar Packaging for the Treatment of Primary and Secondary Dysmenorrhoea |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dysmenorrhea |
| Intervention type | Drug |
| Interventions | Drotaverine, Drotaverine Placebo, Ibuprofen, Ibuprofen Placebo |
| Enrollment | 480 |
| Start date | May 25, 2005 |
| Primary completion | Feb 28, 2006 |
| Completion | Feb 28, 2006 |
| First posted | Feb 16, 2006 |
| Last update posted | Aug 8, 2017 |
| Countries | Hungary |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: